AZ BioVentureHub CEO says aim is an innovative ecosystem

AstraZeneca’s BioVentureHub CEO Magnus Björsne tells Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, about the exchange's intention to generate a climate of open innovation to help grow and nurture the Scandinavian life science ecosystem. AZ BioVentureHub was established in 2014 in Gothenberg, Sweden, aimed at emerging biotech and medtech businesses and academic groups and already has attracted 18 companies, one academic group, four external sponsors and two scientific partners.

Interviewer: Mike Ward – Global Director of Content, Pharma Intelligence, In Vivo/Pink Sheet/Scrip
Interviewee: Magnus Björsne – CEO, AZ BioVenture Hub AB